A much neededFast Track Designation for LX201 for corneal transplant rejectionLux Biosciences http://www.atarax25mg.org.

A much neededFast Track Designation for LX201 for corneal transplant rejectionLux Biosciences, a privately specializing that specializes in the field of eye diseases, announced that the U.S http://www.atarax25mg.org . Food and Drug Administration Fast Track designation is for granted LX201, a silicone matrix ocular implant continuously releases therapeutic doses of cyclosporin A locally to the eye to prevent corneal graft rejection. LX201 in in the one-year central LUCIDA clinical program consisting of two controlled trials investigating the use of LX201 in patients with increased risk of immune-mediated rejection or graft loss after corneal transplant. With this Fast Track designation, we can work faster to a much-needed therapy for the patients, commented Ulrich Grau, President and Chief Executive Officer of Lux If successful, would be the first treatment for the prevention of LX201 corneal graft rejection will to. Unmet medical need. Track drug development program is designed to encourage the development of drugs for life-threatening or very serious diseases to treat and requires that the drug has the potential to date to demonstrate unmet medical need.

– Two Phase III clinical phase projects, including: i) LX211, the oral formulation of a next-generation calcineurin inhibitor as a steroid sparing therapy for the treatment of non-infectious uveitis, and ii) develop LX201, a silicone matrix ocular implant continuously releases therapeutic doses of cyclosporin A on the eye locally to prevent rejection corneal graft recipients. Both Luminate pivotal clinical program for LX211 for the treatment of uveitis, and LUCIDA pivotal clinical program with LX201 for the prevention of corneal graft rejection in early 2007 in early 2007 and in North America and Europe.

The results showed that Vick exposure higher mucus from normal and ignited airways. Beyond the investigations showed the exposure to the product of the rate that mucus cleared removed reduced.

Besides Vick VapoRu decongesting be do not suitable for children. ‘phlegm be one the most effective ways our body protection our airways as lug and bronchial, ‘Rubin said. ‘However, much phlegm and inflammation can cause congestion, very at small lugs. Cough & cold medicines and decongestant are dangerous and neither effective nor safe for young children. Drugs to dry your nasal passages also have problems, ‘Rubin said. ‘.